CURLF - Company ID 0001756770
Curaleaf Holdings, Inc. trades as CURLF and has a market capitalization of $7.19 B, making it the #1154 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.27B, down 5.0% from the prior year and net income of -$231.07M. This page tracks Curaleaf Holdings, Inc. through 176 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 4 fiscal years Curaleaf Holdings, Inc.'s revenue grew from $1.20B to $1.27B, a compound annual growth rate of 1.5%. Net profit margin compressed from -17.2% to -18.2% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-27 |
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-11 |
| 6-K | - | 2026-05-06 |
| 6-K | - | 2026-05-05 |
| 6-K | - | 2026-05-05 |
| 6-K | - | 2026-05-05 |
| 6-K | - | 2026-04-17 |
In consultation with U.S. stock exchanges, Reverse Stock Split prepares Curaleaf for uplisting, in response to U.S. cannabis rescheduling
First quarter 2026 International revenue of $47 million
Mr. Greif is a respected entrepreneur and one of the founders of Four 20 Pharma GmbH, Curaleaf's flagship German brand. With deep expertise in cannabis cultivation, regulatory strategy, and brand development, he has been instrumental in positioning Four 20 Pharma as a leading premium cannabis provider in Germany's emerging medical cannabis market. Under his leadership, the company achieved a majority stake sale to Curaleaf, underscoring his strategic vision, cross-industry approach, and ability to find success in the evolving German cannabis market.
Curaleaf Completes Buyout of Remaining Stake in Germany
Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights.
The largest companies sharing Curaleaf Holdings, Inc.'s SEC industry classification (medicinal chemicals & botanical products).
Curaleaf Holdings, Inc. (CURLF) has a market capitalization of $7.19 B as of 2026-07-09, ranking #1154 among US-listed companies.
Curaleaf Holdings, Inc. reported revenue of $1.27B for fiscal year 2025, a decrease of 5.0% year over year.
In its latest fiscal year Curaleaf Holdings, Inc. reported a net loss of $231.07M.